The Search for a Schistosomiasis Vaccine: Australia's Contribution

Overview

Journal Vaccines (Basel)

Date 2021 Aug 28

PMID 34451997

Citations 6

Authors

Donald P McManus

Affiliations

Soon will be listed here.

Abstract

Schistosomiasis, a neglected tropical disease caused by parasitic flatworms of the genus , results in considerable human morbidity in sub-Saharan Africa, in particular, but also parts of the Middle East, South America, and Southeast Asia. The anti-schistosome drug praziquantel is efficacious and safe against the adult parasites of all species infecting humans; however, it does not prevent reinfection and the development of drug resistance is a constant concern. The need to develop an effective vaccine is of great importance if the health of many in the developing world is to be improved. Indeed, vaccination, in combination with other public health measures, can provide an invaluable tool to achieve lasting control, leading to schistosomiasis elimination. Australia has played a leading role in schistosomiasis vaccine research over many years and this review presents an overview of some of the significant contributions made by Australian scientists in this important area.

Citing Articles

Efficacy of single dose praziquantel against Schistosoma mansoni in East Africa: a systematic review and meta-analysis.

Sisay M, Hailu T, Damtie D, Geta K, Zelalem L, Misganaw D Sci Rep. 2025; 15(1):4642.

PMID: 39920188 PMC: 11806046. DOI: 10.1038/s41598-024-84621-8.

Transmission-Blocking Vaccines against Schistosomiasis Japonica.

Zumuk C, Jones M, Navarro S, Gray D, You H Int J Mol Sci. 2024; 25(3).

PMID: 38338980 PMC: 10855202. DOI: 10.3390/ijms25031707.

Pathological Changes in Hepatic Sinusoidal Endothelial Cells in -Infected Mice.

Jiang T, Wu X, Zhou H, Hu Y, Cao J Trop Med Infect Dis. 2023; 8(2).

PMID: 36828540 PMC: 9959305. DOI: 10.3390/tropicalmed8020124.

Clustered Regularly Interspaced Short Palindromic Repeats/ CRISPR associated protein 9-mediated editing of Schistosoma mansoni genes: Identifying genes for immunologically potent drug and vaccine development.

Naidoo P, Mkhize-Kwitshana Z Rev Soc Bras Med Trop. 2022; 55:e0131.

PMID: 35976333 PMC: 9405935. DOI: 10.1590/0037-8682-0131-2022.

Study of Compounds as Potential Therapeutics Against Schistosomiasis.

Mtemeli F, Shoko R, Ndlovu J, Mugumbate G Bioinform Biol Insights. 2022; 16:11779322221100741.

PMID: 35615403 PMC: 9125113. DOI: 10.1177/11779322221100741.

References

Braschi S, Wilson R . Proteins exposed at the adult schistosome surface revealed by biotinylation. Mol Cell Proteomics. 2005; 5(2):347-56. DOI: 10.1074/mcp.M500287-MCP200. View

Carson J, Robinson M, Hsieh M, Cody J, Le L, You H . A comparative proteomics analysis of the egg secretions of three major schistosome species. Mol Biochem Parasitol. 2020; 240:111322. PMC: 8059868. DOI: 10.1016/j.molbiopara.2020.111322. View

Mulvenna J, Moertel L, Jones M, Nawaratna S, Lovas E, Gobert G . Exposed proteins of the Schistosoma japonicum tegument. Int J Parasitol. 2009; 40(5):543-54. DOI: 10.1016/j.ijpara.2009.10.002. View

McWilliam H, Driguez P, Piedrafita D, Maupin K, Haab B, McManus D . The developing schistosome worms elicit distinct immune responses in different tissue regions. Immunol Cell Biol. 2013; 91(7):477-85. DOI: 10.1038/icb.2013.33. View

You H, McManus D . Vaccines and diagnostics for zoonotic schistosomiasis japonica. Parasitology. 2014; 142(2):271-89. DOI: 10.1017/S0031182014001310. View

Nawaratna S, Gobert G, Willis C, Mulvenna J, Hofmann A, McManus D . Lysosome-associated membrane glycoprotein (LAMP)--preliminary study on a hidden antigen target for vaccination against schistosomiasis. Sci Rep. 2015; 5:15069. PMC: 4607944. DOI: 10.1038/srep15069. View

Hagen J, Scheerlinck J, Gasser R . Knocking down schistosomes - promise for lentiviral transduction in parasites. Trends Parasitol. 2015; 31(7):324-32. DOI: 10.1016/j.pt.2015.03.009. View

McManus D, Bergquist R, Cai P, Ranasinghe S, Tebeje B, You H . Schistosomiasis-from immunopathology to vaccines. Semin Immunopathol. 2020; 42(3):355-371. PMC: 7223304. DOI: 10.1007/s00281-020-00789-x. View

Mitchell G . From PhD to parasites over 25 years: results, discussion and acknowledgements. Immunol Cell Biol. 1990; 68 ( Pt 6):349-57. DOI: 10.1038/icb.1990.48. View

10.

Keitel W, Potter G, Diemert D, Bethony J, El Sahly H, Kennedy J . A phase 1 study of the safety, reactogenicity, and immunogenicity of a Schistosoma mansoni vaccine with or without glucopyranosyl lipid A aqueous formulation (GLA-AF) in healthy adults from a non-endemic area. Vaccine. 2019; 37(43):6500-6509. PMC: 6771426. DOI: 10.1016/j.vaccine.2019.08.075. View

11.

Garcia E, Rivera P, Mitchell G, Evardome R, Almonte R, Tiu W . Effects of induction of anti-embryonation immunity on liver granulomas, spleen weight and portal pressure in mice infected with Schistosoma japonicum. Acta Trop. 1989; 46(2):93-9. DOI: 10.1016/0001-706x(89)90002-8. View

12.

You H, Cai P, Tebeje B, Li Y, McManus D . Schistosome Vaccines for Domestic Animals. Trop Med Infect Dis. 2018; 3(2). PMC: 6073927. DOI: 10.3390/tropicalmed3020068. View

13.

Sotillo J, Pearson M, Potriquet J, Becker L, Pickering D, Mulvenna J . Extracellular vesicles secreted by Schistosoma mansoni contain protein vaccine candidates. Int J Parasitol. 2015; 46(1):1-5. DOI: 10.1016/j.ijpara.2015.09.002. View

14.

Dadara A, Li Y, Xiong T, Zhou J, Williams G, McManus D . DNA-based vaccines protect against zoonotic schistosomiasis in water buffalo. Vaccine. 2008; 26(29-30):3617-25. PMC: 2567122. DOI: 10.1016/j.vaccine.2008.04.080. View

15.

Zhao L, Lu Z, He X, Mughal M, Fang R, Zhou Y . Serine/threonine protein phosphatase 1 (PP1) controls growth and reproduction in Schistosoma japonicum. FASEB J. 2018; :fj201800725R. DOI: 10.1096/fj.201800725R. View

16.

Braschi S, Castro Borges W, Wilson R . Proteomic analysis of the schistosome tegument and its surface membranes. Mem Inst Oswaldo Cruz. 2007; 101 Suppl 1:205-12. DOI: 10.1590/s0074-02762006000900032. View

17.

Gaze S, Driguez P, Pearson M, Mendes T, Doolan D, Trieu A . An immunomics approach to schistosome antigen discovery: antibody signatures of naturally resistant and chronically infected individuals from endemic areas. PLoS Pathog. 2014; 10(3):e1004033. PMC: 3968167. DOI: 10.1371/journal.ppat.1004033. View

18.

Driguez P, McManus D, Gobert G . Clinical implications of recent findings in schistosome proteomics. Expert Rev Proteomics. 2015; 13(1):19-33. DOI: 10.1586/14789450.2016.1116390. View

19.

Gobert G, Moertel L, Brindley P, McManus D . Developmental gene expression profiles of the human pathogen Schistosoma japonicum. BMC Genomics. 2009; 10:128. PMC: 2670322. DOI: 10.1186/1471-2164-10-128. View

20.

Zhang D, Pan W, Qian L, Duke M, Shen L, McManus D . Investigation of recombinant Schistosoma japonicum paramyosin fragments for immunogenicity and vaccine efficacy in mice. Parasite Immunol. 2006; 28(3):77-84. DOI: 10.1111/j.1365-3024.2005.00814.x. View